Immunomodulation by IVIg and the role of Fc-gamma receptors: classic mechanisms of action after all?
Intravenous IgG (IVIg) contains polyclonal IgG from thousands of donors. It is administered at a low dose at regular intervals as antibody replacement therapy and at a higher dose as immunomodulatory treatment in various auto-immune or auto-inflammatory diseases. The working mechanism of immunomodul...
Main Authors: | Sietse Quirijn Nagelkerke, Taco Willem Kuijpers |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00674/full |
Similar Items
-
IgG Glyco-Engineering to Improve IVIg Potency
by: Christine W. Bruggeman, et al.
Published: (2018-10-01) -
Targeting Syk in autoimmune rheumatic diseases
by: GUO-MIN eDENG, et al.
Published: (2016-03-01) -
Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease
by: Takashi Inoue, et al.
Published: (2020-10-01) -
Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways
by: Gina-Maria Lilienthal, et al.
Published: (2018-05-01) -
Delivery of subcutaneous immunoglobulin by rapid “push” infusion for primary immunodeficiency patients in Manitoba: a retrospective review
by: Graham Walter, et al.
Published: (2020-05-01)